about
HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatmentPathobiology of pulmonary arterial hypertension and right ventricular failureHuman immunodeficiency virus-associated pulmonary arterial hypertensionFuture directions: lung aging, inflammation, and human immunodeficiency virusPulmonary arterial hypertension: a comparison between children and adultsThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionMechanisms Underlying HIV Associated Non-infectious Lung Disease.Cardiovascular Complications of HIV in Endemic Countries.Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Isolated right ventricular dysfunction in patients with human immunodeficiency virus.Recent trends in pulmonary arterial hypertensionBlocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.Human immunodeficiency virus and primary pulmonary hypertensionPulmonary arterial hypertension related to human immunodeficiency virus infection: A case series.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertensionPulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspectiveSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.Capsaicin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine pulmonary arteriesPrimary pulmonary hypertension in HIV patients: a systematic review.Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertensionNoninfectious pulmonary complications of human immunodeficiency virus infectionHIV infection is not associated with echocardiographic signs of cardiomyopathy or pulmonary hypertension among pregnant Ugandan women.An official American Thoracic Society Statement: pulmonary hypertension phenotypesEffect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionHuman immunodeficiency virus transgenic rats exhibit pulmonary hypertensionPulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the LiteraturePrimary pulmonary hypertension and human immunodeficiency virus infection.Pathogenesis of Systemic Sclerosis.Echocardiographic findings and their impact on outcomes of critically ill patients with AIDS in the era of HAART.A novel expression of exercise induced pulmonary hypertension in human immunodeficiency virus patients: a pilot study.Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.Sildenafil in the treatment of pulmonary hypertension.Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.Pulmonary hypertension in patients with Martorell hypertensive leg ulcer: a case control studyPathogenic mechanisms of pulmonary arterial hypertension.Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.
P2860
Q26777241-C77691A5-DE30-4F0F-87CC-855EE1E9514AQ26821779-86F9141A-4331-4E48-8ECB-1D8FF90881B1Q26824782-9774BFCB-D858-4E99-95F3-477EE12ACBEDQ26996040-8B7A53E8-D150-4582-BEE6-41E25EE341E0Q27687320-214F5486-7903-4723-93B6-85E50B2643BDQ28386344-97C86BAA-8622-4BB5-976C-2B828DE6B6AEQ30234727-451F83C1-80B5-4AE2-B79D-B1DE503E6DDAQ30244655-F35D411F-C6EC-40C7-AA3B-21AFB9820AE0Q30397068-26741196-AD5E-4A35-8111-414DE081672EQ30410364-E104FD4B-AB62-4D6E-8C12-DC92943954D3Q30475192-4B511E71-3331-4622-BD3B-DAE6CB3E6AA6Q33593640-88E31DAA-0064-4F32-AFEE-35740F64089CQ33604838-BF60A0A8-15B5-47D9-BF6A-10696366E484Q33607782-C4BC38EA-E33F-4628-8D2E-43D845F0847DQ33812960-D6E02619-234D-4696-B995-91CF6367C21DQ33898213-D59CFFDF-1590-4C53-A6ED-EF23743FF714Q33899409-26E9D854-B060-404A-8967-EE4D00AA3EF6Q33965872-56293A88-D4F7-47C3-8BCC-FA12676CE9CDQ34100679-2EF53DE2-F7C7-40AA-B25F-343C95E69D1EQ34155622-87E2139D-BE9C-46CC-ABA3-8DE688178BB6Q34536425-170DFAFA-69EA-423F-A20E-10252B0AEC54Q34564288-F51DBE15-4A38-4809-A790-24040C945CF9Q34777201-34AF5C02-C5F1-4F38-8388-3ED128AC52F0Q34919733-7E339D57-FF10-47E6-94B6-5A63898CAE83Q35132178-47833A91-EC24-4D80-B486-88C645B388D6Q35165691-DED2505C-A3B2-4EC4-BE71-67A8A5B60CCCQ35217383-9D5C8244-42CE-4FAA-B3B3-EE0DCB45F7CBQ35296597-1F87C665-E2A3-4A39-BB09-9DFAD2DE8B4FQ35650162-85DB7954-C050-4286-8E7A-4767BAD526C9Q35693212-22FFD144-261E-4467-AC6A-9BBF89827BB7Q35915065-9F4C67CC-9CE3-4E93-AC96-36C61B761C2EQ35920171-0269E5C6-FFB4-489D-8DB5-B41E72DEF78BQ35979672-3807845C-8B6E-404B-A4E8-F72F1400C24AQ36013070-01EEC9B6-EF18-4DC3-AD66-A10F896554E2Q36026281-831763A9-0667-455C-8B9B-E3F19009E3DEQ36225746-4DB01BC1-1F81-4191-89E1-4FCBEDA994D4Q36314822-E4E98BF6-B52D-4E0B-A35D-C19D7D24FE34Q36316371-EAFEA207-9E66-40D5-BBE4-3B23ACAFCD51Q36447388-B075751E-EBCE-45E4-BB5B-A89A5D081402Q36484894-D472A25C-B491-4490-B148-157808B4F9D1
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Primary pulmonary hypertension in HIV infection.
@en
Primary pulmonary hypertension in HIV infection.
@nl
type
label
Primary pulmonary hypertension in HIV infection.
@en
Primary pulmonary hypertension in HIV infection.
@nl
prefLabel
Primary pulmonary hypertension in HIV infection.
@en
Primary pulmonary hypertension in HIV infection.
@nl
P2093
P356
P1433
P1476
Primary pulmonary hypertension in HIV infection.
@en
P2093
P304
P356
10.1378/CHEST.100.5.1268
P407
P577
1991-11-01T00:00:00Z